JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2003; 41:105-112
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zittermann, A.
Right arrow Articles by Stehle, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zittermann, A.
Right arrow Articles by Stehle, P.

Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?

Armin Zittermann, PhD*,*, Stefanie Schulze Schleithoff*, Gero Tenderich, MD{dagger}, Heiner K. Berthold, MD, PhD{ddagger}, Reiner Körfer, MD{dagger} and Peter Stehle, PhD*

* Department of Nutrition Science, University of Bonn, Germany
{dagger} Heart and Diabetes Center North Rhine-Westfalia, Department of Thoracic and Cardiovascular Surgery, Ruhr-University of Bochum, Bad Oeynhausen, Germany
{ddagger} Center for Cardiovascular Diseases, Department Clinical Pharmacology, Rotenburg a.d. Fulda, Germany



View larger version (19K):

[in a new window]
 
Figure 1 Circulating concentrations (mean ± SD) of 25-hydoxyvitamin D (A) and calcitriol (B) in congestive heart failure (CHF) patients and in elderly healthy controls (≥50 years). Main effects of study groups were observed (analysis of variance; p < 0.001). ***Significant differences between CHF patients and elderly controls, p < 0.001 (post hoc Tukey test); **Significant difference between CHF patients and elderly controls, p < 0.025 (post hoc Tukey test).

 


View larger version (13K):

[in a new window]
 
Figure 2 Blood concentrations (mean ± SD) of N-terminal pro-atrial natriuretic peptide (NT-proANP) in congestive heart failure (CHF) patients and in elderly healthy controls (≥50 years). Main effects of study groups were observed (analysis of variance; p < 0.001). ***Significant differences between CHF patients and elderly controls, p < 0.001 (post hoc Tukey test).

 


View larger version (15K):

[in a new window]
 
Figure 3 Association between serum N-terminal pro-atrial natriuretic peptide (NT-proANP) and serum 25-hydroxyvitamin D values (r2 = 0.16; p < 0.001; regression equation: NT-proANP 4.14·25OHD–0.741).

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2003 by the American College of Cardiology Foundation.